Krebs 2 Carcinoma C0007128
A type of malignant tumor involving uncontrolled cell growth that may invade surrounding tissues. Can affect various organ systems. Treatment typically involves surgery, chemotherapy, or radiation depending on location and stage.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Persistent pain
Hemoptysis
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Unexplained weight loss
(general)Fatigue
(general)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Radical or Partial Nephrectomy
Surgical removal of the kidney tumor, either partially (partial nephrectomy) or entirely (radical nephrectomy), is the primary curative approach for localized kidney cancer. The choice depends on tumor size, location, and kidney function status.
Targeted Therapy or Immunotherapy
Advanced or metastatic kidney cancer is commonly treated with targeted agents such as tyrosine kinase inhibitors or immunotherapy checkpoint inhibitors. These medications help control tumor growth and spread by targeting specific molecular pathways.
Additional treatment options
Thermal Ablation
For small tumors, minimally invasive ablative techniques such as cryoablation or radiofrequency ablation can destroy tumor tissue using extreme temperatures. This approach is particularly useful for patients who are poor surgical candidates.
procedureActive Surveillance
Small, slow-growing tumors may be monitored with regular imaging studies rather than immediate intervention. This approach avoids treatment-related morbidity while ensuring tumors remain under control.
monitoringRadiation Therapy
External beam radiation may be used for localized tumor control, particularly when surgery is not feasible. It can also help relieve symptoms from metastatic disease in bones or other areas.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Krebs 2 Carcinoma C0007128?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Krebs 2 Carcinoma C0007128. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy